Provided by Tiger Trade Technology Pte. Ltd.

BioCardia

1.24
0.0000
Volume:38.39K
Turnover:47.74K
Market Cap:13.16M
PE:-0.75
High:1.28
Open:1.26
Low:1.20
Close:1.24
52wk High:3.20
52wk Low:1.00
Shares:10.61M
Float Shares:4.05M
Volume Ratio:0.67
T/O Rate:0.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6599
EPS(LYR):-2.8960
ROE:-317.47%
ROA:-86.45%
PB:5.01
PE(LYR):-0.43

Loading ...

BioCardia, Inc. Q3 Operating Income USD -1.488 Million

THOMSON REUTERS
·
Nov 13, 2025

BioCardia, Inc. Q3 Basic EPS USD -0.24

THOMSON REUTERS
·
Nov 13, 2025

BioCardia Reports Third Quarter 2025 Business Highlights and Financial Results

GlobeNewswire
·
Nov 13, 2025

BioCardia reports Q3 net loss of $1.5 million on increased R&D expenses

Reuters
·
Nov 13, 2025

BioCardia Q3 EPS $(0.24) Beats $(0.25) Estimate

Benzinga
·
Nov 13, 2025

BioCardia Announces Henry Ford Health Enrolls Their First Patient in Phase 3 Cardiamp HF Ii Cell Therapy Pivotal Trial

THOMSON REUTERS
·
Nov 10, 2025

BioCardia Enrolls First Patient in Phase 3 CardiAMP HF II Heart Failure Trial

Reuters
·
Nov 10, 2025

BioCardia to Host Q3 2025 Corporate Update and Financial Results Conference Call on November 12, 2025

GlobeNewswire
·
Nov 06, 2025

BioCardia Inc. Announces Date for Upcoming Annual Stockholders Meeting

Reuters
·
Nov 03, 2025

BioCardia Enrolls First Patient in Phase 3 CardiAMP HF II Cell Therapy Trial

Reuters
·
Oct 30, 2025

BioCardia Announces University of Wisconsin Enrolls Their First Patient in Phase 3 Cardiamp HF Ii Cell Therapy Pivotal Trial

THOMSON REUTERS
·
Oct 30, 2025

BioCardia’s Innovative Stem Cell Therapy Trial for Heart Failure: Key Updates and Market Impact

TIPRANKS
·
Oct 28, 2025

BioCardia, Inc. - 424B5

THOMSON REUTERS
·
Oct 25, 2025

BioCardia Sets Record Date for Annual Meeting

TIPRANKS
·
Oct 08, 2025

BioCardia Regains Compliance with Nasdaq Listing Requirements

GlobeNewswire
·
Oct 02, 2025

IPS, Inc. Partners with BCDA to Boost Luzon Island’s Digital Infrastructure

TIPRANKS
·
Sep 30, 2025

BioCardia Inc. Granted Nasdaq Extension After Falling Below Stockholders’ Equity Listing Requirement

Reuters
·
Sep 24, 2025

BioCardia Executives Make Bold Moves with Major Stock Purchases

TIPRANKS
·
Sep 24, 2025

Analysts Conflicted on These Healthcare Names: Alector (ALEC), Nurix Therapeutics (NRIX) and BioCardia (BCDA)

TIPRANKS
·
Sep 24, 2025

BioCardia Inc. CEO Peter Altman Reports Acquisition of Common Shares

Reuters
·
Sep 24, 2025